Prediction Markets Regulation and Development
Binance.US is pursuing regulatory approval from the Commodity Futures Trading Commission (CFTC) to launch a prediction market platform, with the company's CEO announcing licensing application plans at a conference. Meanwhile, Goldman Sachs-backed biotech company Attovia Therapeutics is planning an IPO targeting $212.5 million in funding to support development of treatments for immune-mediated diseases.
Key takeaways
- 1.Binance.US is entering the prediction markets sector and seeking formal CFTC regulatory authorization to operate in this space
- 2.The prediction markets industry is experiencing increased competition and regulatory development as major platforms pursue compliance
- 3.Goldman Sachs-backed Attovia Therapeutics is moving forward with public market financing to fund biotech research and development
Outlet bias
Based on Trace's curated lean for each newsroom. Scroll to coverage below to rate any outlet Left / Center / Right yourself.